SLC31A1 and rheumatoid arthritis: Our findings revealed a downregulation of GLS, PDHA1, and FDX1 expression, and an upregulation of NLRP3, DLST, ATP7B, ATP7A, NFE2L2, DBT, and SLC31A1 in whole RA tissues.